Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Brian Koss

Concepts (150)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Experimental
2
2020
114
0.820
Why?
Small Molecule Libraries
3
2019
68
0.770
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
55
0.720
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
78
0.700
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2016
10
0.640
Why?
Biomimetic Materials
1
2016
9
0.540
Why?
Proto-Oncogene Proteins
1
2016
149
0.510
Why?
Peptide Fragments
1
2016
213
0.490
Why?
Histones
3
2024
313
0.490
Why?
Cell Lineage
2
2014
84
0.470
Why?
Melanoma
3
2023
290
0.450
Why?
Fusion Proteins, bcr-abl
1
2013
20
0.450
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2013
92
0.410
Why?
Mice
13
2023
5759
0.380
Why?
Cell Line, Tumor
6
2020
1416
0.340
Why?
Apoptosis
8
2023
1112
0.340
Why?
Proto-Oncogene Proteins c-bcl-2
4
2014
129
0.310
Why?
Antineoplastic Agents
3
2023
1186
0.290
Why?
Animals
13
2023
13246
0.280
Why?
Ubiquitination
2
2024
43
0.260
Why?
Tumor Microenvironment
3
2023
233
0.240
Why?
Antigen Presentation
1
2023
25
0.230
Why?
Gene Rearrangement
1
2024
74
0.220
Why?
Chromatin
1
2024
152
0.220
Why?
Mice, Transgenic
2
2016
550
0.220
Why?
DNA-Activated Protein Kinase
1
2023
26
0.210
Why?
Neoplasms
3
2023
1249
0.210
Why?
Cell Survival
5
2019
602
0.210
Why?
Mice, Inbred C57BL
4
2016
1819
0.210
Why?
DNA Damage
1
2024
301
0.210
Why?
Leukemia, Myeloid, Acute
1
2024
185
0.200
Why?
Tumor Suppressor Protein p53
1
2023
203
0.190
Why?
Hematologic Neoplasms
1
2023
99
0.190
Why?
Histone Code
2
2020
32
0.190
Why?
Epigenesis, Genetic
2
2020
378
0.180
Why?
Transcription Factors
2
2023
564
0.170
Why?
Xenograft Model Antitumor Assays
2
2019
212
0.170
Why?
Polycomb Repressive Complex 2
1
2019
47
0.170
Why?
Integrin alpha Chains
1
2019
11
0.160
Why?
Tumor Cells, Cultured
2
2019
468
0.160
Why?
Cell Cycle Checkpoints
1
2019
32
0.160
Why?
Cadherins
1
2019
68
0.160
Why?
Melanoma, Experimental
1
2019
45
0.160
Why?
Antigens, CD
1
2019
221
0.150
Why?
CTLA-4 Antigen
1
2017
25
0.140
Why?
Humans
16
2024
50208
0.140
Why?
Programmed Cell Death 1 Receptor
1
2017
39
0.140
Why?
DNA-Binding Proteins
1
2019
428
0.140
Why?
Transfection
1
2016
355
0.130
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2014
1
0.120
Why?
Granulocytes
1
2014
26
0.120
Why?
Drug Resistance, Neoplasm
1
2017
314
0.120
Why?
Myeloid Cells
1
2014
38
0.120
Why?
Protein Processing, Post-Translational
2
2020
171
0.120
Why?
CD8-Positive T-Lymphocytes
3
2023
128
0.120
Why?
Monocytes
1
2014
131
0.120
Why?
Gene Expression Regulation, Leukemic
1
2013
33
0.110
Why?
Antibodies, Monoclonal
1
2017
460
0.110
Why?
Lung Neoplasms
1
2019
605
0.110
Why?
Cells, Cultured
2
2013
1581
0.100
Why?
High-Throughput Screening Assays
1
2012
36
0.100
Why?
B-Lymphocytes
1
2013
170
0.100
Why?
Mitochondria
2
2013
404
0.100
Why?
Peptides
1
2012
223
0.100
Why?
Ubiquitin
1
2010
45
0.090
Why?
Ubiquitin-Protein Ligases
2
2024
95
0.080
Why?
Disease Models, Animal
1
2013
1458
0.080
Why?
T-Lymphocytes
2
2023
339
0.080
Why?
Structure-Activity Relationship
2
2019
401
0.060
Why?
Multiple Myeloma
1
2019
2954
0.060
Why?
Camptothecin
1
2024
16
0.060
Why?
BRCA1 Protein
1
2024
31
0.060
Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
14
0.060
Why?
Proto-Oncogenes
1
2024
27
0.060
Why?
Major Histocompatibility Complex
1
2023
12
0.060
Why?
Interferons
1
2023
38
0.060
Why?
Cell Proliferation
2
2019
1013
0.060
Why?
Histocompatibility Antigens Class I
1
2023
44
0.060
Why?
HEK293 Cells
1
2024
224
0.060
Why?
Proto-Oncogene Proteins c-ret
1
2024
33
0.060
Why?
HLA Antigens
1
2023
53
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2024
198
0.050
Why?
Cell Cycle Proteins
1
2024
166
0.050
Why?
DNA Repair
1
2024
193
0.050
Why?
Cell Respiration
2
2013
42
0.050
Why?
Microscopy, Electron, Transmission
2
2013
75
0.050
Why?
Antigens, Neoplasm
1
2023
152
0.050
Why?
Phosphorylation
1
2024
534
0.050
Why?
CD4-Positive T-Lymphocytes
1
2023
164
0.050
Why?
Immunotherapy, Adoptive
1
2023
157
0.050
Why?
Promoter Regions, Genetic
1
2023
475
0.050
Why?
Proteomics
1
2023
330
0.050
Why?
Workflow
1
2020
51
0.040
Why?
DNA
1
2023
541
0.040
Why?
Azepines
1
2019
18
0.040
Why?
Methylation
1
2019
123
0.040
Why?
Oxidative Stress
1
2024
771
0.040
Why?
Molecular Dynamics Simulation
1
2019
33
0.040
Why?
Mice, Inbred NOD
1
2019
96
0.040
Why?
Crystallography, X-Ray
1
2019
148
0.040
Why?
Mice, SCID
1
2019
176
0.040
Why?
Drug Evaluation, Preclinical
1
2019
143
0.040
Why?
Protein Structure, Tertiary
1
2019
253
0.040
Why?
Binding Sites
1
2019
375
0.040
Why?
Membrane Potential, Mitochondrial
1
2016
39
0.040
Why?
Immunoprecipitation
1
2016
59
0.040
Why?
Epithelial-Mesenchymal Transition
1
2017
48
0.040
Why?
bcl-X Protein
1
2016
50
0.030
Why?
Drug Design
1
2016
121
0.030
Why?
Drug Discovery
1
2016
88
0.030
Why?
Proteome
1
2017
173
0.030
Why?
Fas-Associated Death Domain Protein
1
2014
6
0.030
Why?
Caspase 8
1
2014
12
0.030
Why?
Minor Histocompatibility Antigens
1
2014
17
0.030
Why?
Neoplasm Transplantation
1
2014
85
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2019
828
0.030
Why?
Coculture Techniques
1
2014
146
0.030
Why?
Immune Tolerance
1
2014
95
0.030
Why?
RNA, Small Interfering
1
2014
215
0.030
Why?
Mice, 129 Strain
1
2013
38
0.030
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2013
17
0.030
Why?
Sequence Deletion
1
2013
67
0.030
Why?
bcl-2-Associated X Protein
1
2013
56
0.030
Why?
Proton-Translocating ATPases
1
2012
9
0.030
Why?
Oxygen Consumption
1
2013
188
0.030
Why?
Membrane Potentials
1
2012
117
0.030
Why?
Mice, Knockout
1
2014
846
0.030
Why?
Cell Differentiation
1
2014
650
0.020
Why?
Models, Molecular
1
2012
341
0.020
Why?
Adenosine Triphosphate
1
2012
233
0.020
Why?
Child
1
2023
6851
0.020
Why?
Hematopoietic System
1
2010
3
0.020
Why?
Leupeptins
1
2010
7
0.020
Why?
Cycloheximide
1
2010
39
0.020
Why?
Myocardium
1
2013
438
0.020
Why?
Embryo, Mammalian
1
2010
66
0.020
Why?
Mutant Proteins
1
2010
37
0.020
Why?
Half-Life
1
2010
87
0.020
Why?
Protein Stability
1
2010
44
0.020
Why?
Alleles
1
2010
251
0.020
Why?
Treatment Outcome
1
2020
5155
0.020
Why?
Proteasome Inhibitors
1
2010
104
0.020
Why?
Dose-Response Relationship, Drug
1
2012
1378
0.020
Why?
Fibroblasts
1
2010
351
0.020
Why?
Signal Transduction
1
2014
1622
0.020
Why?
Heart Failure
1
2013
506
0.020
Why?
Muscle, Skeletal
1
2013
765
0.020
Why?
Cell Line
1
2010
1021
0.020
Why?
Mutation
1
2010
1294
0.010
Why?
Female
1
2019
26635
0.010
Why?
Koss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description